167 related articles for article (PubMed ID: 16817891)
1. Physiochemical characterization of the Alzheimer's disease-related peptides A beta 1-42Arctic and A beta 1-42wt.
Johansson AS; Berglind-Dehlin F; Karlsson G; Edwards K; Gellerfors P; Lannfelt L
FEBS J; 2006 Jun; 273(12):2618-30. PubMed ID: 16817891
[TBL] [Abstract][Full Text] [Related]
2. Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease.
Harper JD; Wong SS; Lieber CM; Lansbury PT
Biochemistry; 1999 Jul; 38(28):8972-80. PubMed ID: 10413470
[TBL] [Abstract][Full Text] [Related]
3. Unique physicochemical profile of beta-amyloid peptide variant Abeta1-40E22G protofibrils: conceivable neuropathogen in arctic mutant carriers.
Päiviö A; Jarvet J; Gräslund A; Lannfelt L; Westlind-Danielsson A
J Mol Biol; 2004 May; 339(1):145-59. PubMed ID: 15123427
[TBL] [Abstract][Full Text] [Related]
4. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.
Nilsberth C; Westlind-Danielsson A; Eckman CB; Condron MM; Axelman K; Forsell C; Stenh C; Luthman J; Teplow DB; Younkin SG; Näslund J; Lannfelt L
Nat Neurosci; 2001 Sep; 4(9):887-93. PubMed ID: 11528419
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.
Kirkitadze MD; Condron MM; Teplow DB
J Mol Biol; 2001 Oct; 312(5):1103-19. PubMed ID: 11580253
[TBL] [Abstract][Full Text] [Related]
6. Abeta protofibrils possess a stable core structure resistant to hydrogen exchange.
Kheterpal I; Lashuel HA; Hartley DM; Walz T; Lansbury PT; Wetzel R
Biochemistry; 2003 Dec; 42(48):14092-8. PubMed ID: 14640676
[TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic acid stabilizes soluble amyloid-beta protofibrils and sustains amyloid-beta-induced neurotoxicity in vitro.
Johansson AS; Garlind A; Berglind-Dehlin F; Karlsson G; Edwards K; Gellerfors P; Ekholm-Pettersson F; Palmblad J; Lannfelt L
FEBS J; 2007 Feb; 274(4):990-1000. PubMed ID: 17227385
[TBL] [Abstract][Full Text] [Related]
8. Nordihydroguaiaretic acid does not disaggregate beta-amyloid(1-40) protofibrils but does inhibit growth arising from direct protofibril association.
Moss MA; Varvel NH; Nichols MR; Reed DK; Rosenberry TL
Mol Pharmacol; 2004 Sep; 66(3):592-600. PubMed ID: 15322251
[TBL] [Abstract][Full Text] [Related]
9. Direct visualisation of the beta-sheet structure of synthetic Alzheimer's amyloid.
Serpell LC; Smith JM
J Mol Biol; 2000 May; 299(1):225-31. PubMed ID: 10860734
[TBL] [Abstract][Full Text] [Related]
10. Environment- and mutation-dependent aggregation behavior of Alzheimer amyloid beta-protein.
Yamamoto N; Hasegawa K; Matsuzaki K; Naiki H; Yanagisawa K
J Neurochem; 2004 Jul; 90(1):62-9. PubMed ID: 15198667
[TBL] [Abstract][Full Text] [Related]
11. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
12. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
Benseny-Cases N; Cócera M; Cladera J
Biochem Biophys Res Commun; 2007 Oct; 361(4):916-21. PubMed ID: 17679138
[TBL] [Abstract][Full Text] [Related]
13. In-situ atomic force microscopy study of beta-amyloid fibrillization.
Blackley HK; Sanders GH; Davies MC; Roberts CJ; Tendler SJ; Wilkinson MJ
J Mol Biol; 2000 May; 298(5):833-40. PubMed ID: 10801352
[TBL] [Abstract][Full Text] [Related]
14. First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro.
Naiki H; Nakakuki K
Lab Invest; 1996 Feb; 74(2):374-83. PubMed ID: 8780157
[TBL] [Abstract][Full Text] [Related]
15. Quartz crystal microbalance analysis of growth kinetics for aggregation intermediates of the amyloid-beta protein.
Kotarek JA; Johnson KC; Moss MA
Anal Biochem; 2008 Jul; 378(1):15-24. PubMed ID: 18396143
[TBL] [Abstract][Full Text] [Related]
16. The peptide KLVFF-K(6) promotes beta-amyloid(1-40) protofibril growth by association but does not alter protofibril effects on cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT).
Moss MA; Nichols MR; Reed DK; Hoh JH; Rosenberry TL
Mol Pharmacol; 2003 Nov; 64(5):1160-8. PubMed ID: 14573766
[TBL] [Abstract][Full Text] [Related]
17. Sensitive ELISA detection of amyloid-beta protofibrils in biological samples.
Englund H; Sehlin D; Johansson AS; Nilsson LN; Gellerfors P; Paulie S; Lannfelt L; Pettersson FE
J Neurochem; 2007 Oct; 103(1):334-45. PubMed ID: 17623042
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of formation of amyloid protofibrils of barstar from soluble oligomers: evidence for multiple steps and lateral association coupled to conformational conversion.
Kumar S; Mohanty SK; Udgaonkar JB
J Mol Biol; 2007 Apr; 367(4):1186-204. PubMed ID: 17292913
[TBL] [Abstract][Full Text] [Related]
19. Growth of beta-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy.
Nichols MR; Moss MA; Reed DK; Lin WL; Mukhopadhyay R; Hoh JH; Rosenberry TL
Biochemistry; 2002 May; 41(19):6115-27. PubMed ID: 11994007
[TBL] [Abstract][Full Text] [Related]
20. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template.
Ha C; Park CB
Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
